Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Oncolytics Bio (ONC.TO)

Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 98,377
  • Shares Outstanding, K 76,857
  • Annual Sales, $ 0 K
  • Annual Income, $ -27,752 K
  • 60-Month Beta 1.20
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.37
Trade ONC.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.38
  • Most Recent Earnings $-0.10 on 08/01/24
  • Next Earnings Date 11/01/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.11
  • Number of Estimates 2
  • High Estimate -0.10
  • Low Estimate -0.11
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +21.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.22 +6.56%
on 08/30/24
1.39 -6.47%
on 09/04/24
-0.02 (-1.52%)
since 08/19/24
3-Month
1.20 +8.33%
on 08/13/24
1.50 -13.33%
on 07/16/24
-0.09 (-6.47%)
since 06/19/24
52-Week
1.20 +8.33%
on 08/13/24
3.10 -58.06%
on 09/27/23
-1.51 (-53.74%)
since 09/19/23

Most Recent Stories

More News
Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players

/CNW/ -- USA News Group – In the oncology world, there's been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years. However,...

ONCY : 0.9498 (+2.13%)
NVS : 116.12 (+0.13%)
LNTH : 107.95 (-0.18%)
STRO : 3.90 (-1.27%)
ZYME : 13.04 (+4.15%)
ONC.TO : 1.29 (+0.39%)
Recent Breakthroughs in Cancer Research Could Impact These Key Companies

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – In the oncology world, there’s...

ONCY : 0.9498 (+2.13%)
ONC.TO : 1.29 (+0.39%)
NVS : 116.12 (+0.13%)
LNTH : 107.95 (-0.18%)
STRO : 3.90 (-1.27%)
ZYME : 13.04 (+4.15%)
Stocks in play: Oncolytics Biotech Inc

Announced positive clinical results from BRACELET-1, its randomized Phase 2 study evaluating pelareorep ...

ONC.TO : 1.29 (+0.39%)
Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study

Overall survival (OS) results from BRACELET-1 corroborate results of previous randomized IND-213 breast cancer study Together, these two studies support the...

ONCY : 0.9498 (+2.13%)
ONC.TO : 1.29 (+0.39%)
Stocks in play: Oncolytics Biotech Inc

Announced that Chief Financial Officer Kirk Look will participate in a fireside chat at the H.C. Wainwright ...

ONC.TO : 1.29 (+0.39%)
Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 0.9498 (+2.13%)
ONC.TO : 1.29 (+0.39%)
Biotech Innovations: Revolutionary Treatments Aim to Boost Pancreatic Cancer Survival Rates

/CNW/ -- USA News Group – Pancreatic cancer is among the deadliest cancers, prompting researchers to focus on early detection to improve survival rates. Johns...

ONCY : 0.9498 (+2.13%)
HALO : 59.42 (-4.64%)
CADL : 7.64 (-1.55%)
MRUS : 50.65 (+2.49%)
RHHBY : 39.4800 (-0.33%)
ONC.TO : 1.29 (+0.39%)
Biotech Innovations Poised to Transform Pancreatic Cancer Treatment and Patient Outcomes

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – Pancreatic cancer is among the...

ONCY : 0.9498 (+2.13%)
ONC.TO : 1.29 (+0.39%)
RHHBY : 39.4800 (-0.33%)
HALO : 59.42 (-4.64%)
CADL : 7.64 (-1.55%)
MRUS : 50.65 (+2.49%)
Stocks in play: Oncolytics Biotech® Inc.

Announced that Chief Medical Officer Dr. Thomas Heineman will participate in a fireside chat at Canaccord ...

ONC.TO : 1.29 (+0.39%)
Stocks in play: Oncolytics Biotech Inc

Today announced that Chief Medical Officer Dr. Thomas Heineman will participate in a fireside chat at ...

ONC.TO : 1.29 (+0.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the...

See More

Key Turning Points

3rd Resistance Point 1.35
2nd Resistance Point 1.33
1st Resistance Point 1.31
Last Price 1.29
1st Support Level 1.27
2nd Support Level 1.25
3rd Support Level 1.23

See More

52-Week High 3.10
Fibonacci 61.8% 2.37
Fibonacci 50% 2.15
Fibonacci 38.2% 1.93
Last Price 1.29
52-Week Low 1.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar